AI-generated · cited to primary sources · not investment advice
Fortis Health. (532843) Nov 2025 Filing Analysis
Does management do what it says?
The company has achieved a 300 basis point improvement in consolidated operating EBITDA margins for the 9-month period, surpassing the full-year target of 200 bps. (1 exceeded, 1 met across 2 tracked commitments)
“As we have guided earlier also, it was -- the margins for -- if you see the half year, we are around 24%. So I think we'll be somewhere around the 23%, 24% for the whole year is what we are expecting.”
Management reported adding approximately 750 operational beds so far in FY26, significantly exceeding the initial full-year target of 400-500 beds due to aggressive inorganic growth. (1 exceeded, 2 revised, 1 met across 4 tracked commitments)
“Neha Manpuria: Okay. And second -- and so we still maintain the full year addition of about 400, 500 beds? Ashutosh Raghuvanshi: That's correct. . Yes, that's right.”
For the 9-month period, hospital business operating margins reached 22.2%. While slightly below the 22.5% stretch target, it shows significant improvement from 20% in the previous year. (2 in progress across 2 tracked commitments)
“So I think there is a possibility we can see higher margin improvement than what we have guided at the beginning of the year. To quantify it will be a bit higher.”
Fortis has entered into an O&M agreement for a 550-bedded super specialty hospital to be constructed in Lucknow. — target: 550 beds
“Aug’25 : Fortis entered into collaboration agreement for Operations and Management (O&M) of 550 bedded greenfield super specialty hospital to be constructed in Lucknow by the Ekana Group.”
See the full cited Management analysis of Fortis Health.
How durable is the business?
Operating EBITDA margins for the hospital business improved from 21.4% to 22.9%, reflecting better operating leverage despite a slight dip in occupancy from 72% to 71%. (1 expanding)
“Operating EBITDA margin at 22.9% vs 21.4% in Q2 FY25”
International patient revenue grew 26% to INR 169 Cr, increasing its share of total hospital revenue from 7.7% to 8.1%, signaling strong recovery in medical tourism. (1 expanding)
“International Patient revenues grew 26% to INR 169 Cr in Q2 FY26 vs INR 135 Cr in Q2 FY25. The business contributed to 8.1% to overall hospital business revenues”
See the full cited Business Model analysis of Fortis Health.
Where does growth come from?
The impact of CGHS rate revisions is currently being evaluated. While management expects a positive impact on revenue, they are cautious about drug price restrictions and payment predictability (180-day cycle). (1 steady across 1 signal)
“And our government payer where this particular CGHS also come is generally contributing 18% to 20% of our total overall revenue... Looking like it will be a positive impact.”
See the full cited Future Growth analysis of Fortis Health.
What could break the thesis?
The integration is now progressing well under a new operation and management services agreement for five hospitals and a clinic. Management expects to eventually evaluate a full merger/integration. (1 easing, 1 intensifying)
“The integration of Gleneagles units under the agreement with Fortis is progressing well.”
See the full cited Risk analysis of Fortis Health.
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.